← Back to catalogue

Novocastra™

FDA UDI

Class I (US FDA UDI)

by Leica Biosystems Newcastle, Limited

Identity

Trade Name
Novocastra™ FDA UDI
Generic Name
Vascular endothelial growth factor (VEGF) IVD, antibody FDA UDI
Device Name
Analyte Specific Reagnet. Analytical and performance characteristics are not established. FDA UDI
Model / Reference
VEGFR3-L-A FDA UDI
Description
Analyte Specific Reagnet. Analytical and performance characteristics are not established. FDA UDI

Identifiers

Catalog Number
NCL-L-VEGFR3 FDA UDI
Primary DI / UDI-DI
05055331300430 FDA UDI
FDA Product Code
MVU FDA UDI
GMDN Term
Vascular endothelial growth factor (VEGF) IVD, antibody FDA UDI

Classification

Device Class
Class I FDA UDI
Regulation Number
864.4020 FDA UDI
Commercial Distribution
In Commercial Distribution FDA UDI

Clinical & Handling

Sterile

No

FDA UDI

Single Use

No

FDA UDI

Implantable

No

FDA UDI

Contains Latex

No

FDA UDI

Prescription Use

Yes

FDA UDI

Over-the-Counter

No

FDA UDI

Convenience Kit

No

FDA UDI

Combination Product

No

FDA UDI

HCT/P

No

FDA UDI

Premarket Exempt

Yes

FDA UDI

Lot / Batch Number

Yes

FDA UDI

Serial Number

No

FDA UDI

Expiration Date

Yes

FDA UDI

Manufacturing Date

No

FDA UDI

Category: Vascular endothelial growth factor (VEGF) IVD, antibody

Novocastra™ by Leica Biosystems Newcastle, Limited — Class I — FDA UDI — listed in FDA GUDID — regulatory data on deviCERTS

Similar devices

Also classified as Vascular endothelial growth factor (VEGF) IVD, antibody.

Authorization Coverage (1 country)

Regulatory Authorizations

United States Pending data

FDA UDI

Is this your device? Claim it to add documentation and request validation.

Manufacturer

Sources (1)

  • FDA UDI 78042893-26b3-4dbf-94d7-28a8b165e207 36 fields · synced May 30, 2026